Predictive Oncology Inc.
POAI
$5.85
$0.305.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.60K | 2.70K | 110.30K | 611.60K | 3.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.60K | 2.70K | 110.30K | 611.60K | 3.90K |
| Cost of Revenue | 8.40K | 18.20K | 45.10K | 290.60K | 11.20K |
| Gross Profit | -4.70K | -15.50K | 65.20K | 321.00K | -7.30K |
| SG&A Expenses | 3.28M | 2.64M | 2.35M | 2.44M | 2.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.28M | 2.66M | 2.40M | 2.74M | 2.16M |
| Operating Income | -3.28M | -2.66M | -2.29M | -2.12M | -2.16M |
| Income Before Tax | -77.65M | -1.98M | -2.29M | -2.10M | -2.13M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -77.65M | -1.98M | -2.29M | -2.10M | -2.13M |
| Earnings from Discontinued Operations | -5.10K | -91.60K | -157.50K | -68.70K | -964.80K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -77.65M | -2.07M | -2.44M | -2.17M | -3.09M |
| EBIT | -3.28M | -2.66M | -2.29M | -2.12M | -2.16M |
| EBITDA | -3.25M | -2.63M | -2.25M | -2.08M | -2.13M |
| EPS Basic | -107.25 | -3.41 | -5.12 | -4.87 | -7.26 |
| Normalized Basic EPS | -67.03 | -2.04 | -3.00 | -2.95 | -3.12 |
| EPS Diluted | -107.25 | -3.45 | -5.13 | -4.87 | -7.26 |
| Normalized Diluted EPS | -67.03 | -2.04 | -3.00 | -2.95 | -3.12 |
| Average Basic Shares Outstanding | 724.00K | 607.30K | 476.80K | 445.10K | 426.40K |
| Average Diluted Shares Outstanding | 724.00K | 607.30K | 476.80K | 445.10K | 426.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |